Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 121

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Chronic Obstructive Pulmonary Disease

O’Donnell, Denis E., Laveneziana, Pierantonio, Webb, Katherine, Neder, J. Alberto·2014·Clinics in Chest Medicine
DOI 10.1016/j.ccm.2013.09.008
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccm.2013.09.008

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 154

  1. Buist, 2007, International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study, Lancet, 370, 741, 10.1016/S0140-6736(07)61377-4 · DOI
  2. Mannino, 2003, Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study, Thorax, 58, 388, 10.1136/thorax.58.5.388 · DOI · Paper page
  3. Lange, 2012, Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population, Am J Respir Crit Care Med, 186, 975, 10.1164/rccm.201207-1299OC · DOI
  4. Maleki-Yazdi, 2007, Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study, COPD, 4, 313, 10.1080/15412550701595740 · DOI
  5. Antonelli-Incalzi, 2003, Do GOLD stages of COPD severity really correspond to differences in health status?, Eur Respir J, 22, 444, 10.1183/09031936.03.00101203 · DOI
  6. Ferrer, 1997, Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group, Ann Intern Med, 127, 1072, 10.7326/0003-4819-127-12-199712150-00003 · DOI
  7. Jones, 2001, Health status measurement in chronic obstructive pulmonary disease, Thorax, 56, 880, 10.1136/thorax.56.11.880 · DOI
  8. Jones, 2009, Development and first validation of the COPD assessment test, Eur Respir J, 34, 648, 10.1183/09031936.00102509 · DOI
  9. Decramer, 2008, COPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early intervention, COPD, 5, 235, 10.1080/15412550802237531 · DOI
  10. Watz, 2008, Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study, Am J Respir Crit Care Med, 177, 743, 10.1164/rccm.200707-1011OC · DOI
  11. Walker, 2008, Lower limb activity and its determinants in COPD, Thorax, 63, 683, 10.1136/thx.2007.087130 · DOI
  12. Steuten, 2006, COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care, Prim Care Respir J, 15, 84, 10.1016/j.pcrj.2005.09.001 · DOI
  13. Guenette, 2011, Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms, Respir Physiol Neurobiol, 177, 218, 10.1016/j.resp.2011.04.011 · DOI · Paper page
  14. O'Donnell, 2009, Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD, Thorax, 64, 216, 10.1136/thx.2008.103598 · DOI · Paper page
  15. Chin, 2013, Does the respiratory system limit exercise in mild COPD?, Am J Respir Crit Care Med, 187, 1315, 10.1164/rccm.201211-1970OC · DOI · Paper page
  16. Deesomchok, 2010, Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity, COPD, 7, 428, 10.3109/15412555.2010.528087 · DOI · Paper page
  17. Yuan, 2009, Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography, Thorax, 64, 944, 10.1136/thx.2008.112433 · DOI · Paper page
  18. Rambod, 2012, Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort, Chest, 141, 867, 10.1378/chest.11-0870 · DOI
  19. Matsuoka, 2010, Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation, Acad Radiol, 17, 93, 10.1016/j.acra.2009.07.022 · DOI
  20. Hogg, 1968, Site and nature of airway obstruction in chronic obstructive lung disease, N Engl J Med, 278, 1355, 10.1056/NEJM196806202782501 · DOI · Paper page
  21. Hogg, 2004, The nature of small-airway obstruction in chronic obstructive pulmonary disease, N Engl J Med, 350, 2645, 10.1056/NEJMoa032158 · DOI
  22. McDonough, 2011, Small-airway obstruction and emphysema in chronic obstructive pulmonary disease, N Engl J Med, 365, 1567, 10.1056/NEJMoa1106955 · DOI · Paper page
  23. Mitzner, 2011, Emphysema: a disease of small airways or lung parenchyma?, N Engl J Med, 365, 1637, 10.1056/NEJMe1110635 · DOI
  24. Black, 1972, Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1-antitrypsin deficiency, Am Rev Respir Dis, 105, 891
  25. Leaver, 1973, Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema, J Clin Invest, 52, 2117, 10.1172/JCI107396 · DOI
  26. Corbin, 1979, A four-year follow-up study of lung mechanics in smokers, Am Rev Respir Dis, 120, 293
  27. Woolcock, 1969, Frequency dependence of compliance as a test for obstruction in the small airways, J Clin Invest, 48, 1097, 10.1172/JCI106066 · DOI
  28. Buist, 1988, Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation?, Am Rev Respir Dis, 137, 293, 10.1164/ajrccm/137.2.293 · DOI
  29. Hutcheon, 1974, Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics, Am Rev Respir Dis, 110, 458
  30. Dosman, 1975, The use of a helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers, J Clin Invest, 55, 1090, 10.1172/JCI108010 · DOI
  31. Coe, 1989, Effects of smoking on changes in respiratory resistance with increasing age, Clin Sci (Lond), 76, 487, 10.1042/cs0760487 · DOI
  32. Crim, 2011, Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results, Respir Med, 105, 1069, 10.1016/j.rmed.2011.01.010 · DOI
  33. Fry, 1960, Pulmonary mechanics. A unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjects, Am J Med, 29, 672, 10.1016/0002-9343(60)90100-5 · DOI
  34. Gelb, 1973, Physiologic diagnosis of subclinical emphysema, Am Rev Respir Dis, 107, 50
  35. Knudson, 1976, The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study, Am Rev Respir Dis, 114, 871
  36. Rijcken, 1989, The distribution of bronchial responsiveness to histamine in symptomatic and in asymptomatic subjects. A population-based analysis of various indices of responsiveness, Am Rev Respir Dis, 140, 615, 10.1164/ajrccm/140.3.615 · DOI
  37. Rijcken, 1988, The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample, Am Rev Respir Dis, 137, 826, 10.1164/ajrccm/137.4.826 · DOI
  38. Buist, 1993, Chronic obstructive pulmonary disease early intervention trial (lung health study). Baseline characteristics of randomized participants, Chest, 103, 1863, 10.1378/chest.103.6.1863 · DOI
  39. Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 · DOI
  40. Riess, 1996, Morphologic determinants of airway responsiveness in chronic smokers, Am J Respir Crit Care Med, 154, 1444, 10.1164/ajrccm.154.5.8912762 · DOI
  41. Rodriguez-Roisin, 2009, Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity, J Appl Physiol, 106, 1902, 10.1152/japplphysiol.00085.2009 · DOI · Paper page
  42. Wagner, 1977, Ventilation-perfusion inequality in chronic obstructive pulmonary disease, J Clin Invest, 59, 203, 10.1172/JCI108630 · DOI
  43. Barbera, 1994, Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 149, 423, 10.1164/ajrccm.149.2.8306040 · DOI
  44. Barbera, 1990, Lung structure and gas exchange in mild chronic obstructive pulmonary disease, Am Rev Respir Dis, 141, 895, 10.1164/ajrccm/141.4_Pt_1.895 · DOI
  45. Peinado, 1998, Endothelial dysfunction in pulmonary arteries of patients with mild COPD, Am J Physiol, 274, L908
  46. Santos, 2002, Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD, Eur Respir J, 19, 632, 10.1183/09031936.02.00245902 · DOI
  47. O’Donnell, 2012, Lung function and exercise impairment in patients with GOLD stage I and II COPD, Am J Respir Crit Care Med, 185, A5875
  48. McParland, 1991, Respiratory adaptations to dead space loading during maximal incremental exercise, J Appl Physiol, 70, 55, 10.1152/jappl.1991.70.1.55 · DOI
  49. Syabbalo, 1993, Carotid chemoreceptors and respiratory adaptations to dead space loading during incremental exercise, J Appl Physiol, 75, 1378, 10.1152/jappl.1993.75.3.1378 · DOI
  50. O'Donnell, 2000, Respiratory sensation during chest wall restriction and dead space loading in exercising men, J Appl Physiol, 88, 1859, 10.1152/jappl.2000.88.5.1859 · DOI
  51. Vonk-Noordegraaf, 2005, Early changes of cardiac structure and function in COPD patients with mild hypoxemia, Chest, 127, 1898, 10.1378/chest.127.6.1898 · DOI
  52. Mannino, 2006, Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study, Respir Med, 100, 115, 10.1016/j.rmed.2005.03.035 · DOI
  53. Barr, 2010, Percent emphysema, airflow obstruction, and impaired left ventricular filling, N Engl J Med, 362, 217, 10.1056/NEJMoa0808836 · DOI · Paper page
  54. Sabit, 2010, Sub-clinical left and right ventricular dysfunction in patients with COPD, Respir Med, 104, 1171, 10.1016/j.rmed.2010.01.020 · DOI
  55. Malerba, 2011, Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease, J Biol Regul Homeost Agents, 25, 443
  56. Grau, 2013, Percent emphysema and right ventricular structure and function: the MESA Lung and MESA-RV Studies, Chest, 144, 136, 10.1378/chest.12-1779 · DOI
  57. Smith, 2013, Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study, Circulation, 127, 1503, 10.1161/CIRCULATIONAHA.113.001653 · DOI
  58. Thomashow, 2013, Endothelial microparticles in mild COPD and emphysema: the MESA COPD Study, Am J Respir Crit Care Med, 188, 60, 10.1164/rccm.201209-1697OC · DOI
  59. Sin, 2005, The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature, Chest, 127, 1952, 10.1378/chest.127.6.1952 · DOI
  60. Iwamoto, 2009, Airflow limitation in smokers is associated with subclinical atherosclerosis, Am J Respir Crit Care Med, 179, 35, 10.1164/rccm.200804-560OC · DOI
  61. Barr, 2011, The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema, Proc Am Thorac Soc, 8, 522, 10.1513/pats.201101-008MW · DOI
  62. Barbera, 2001, Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers, Am J Respir Crit Care Med, 164, 709, 10.1164/ajrccm.164.4.2101023 · DOI
  63. Cheng, 2009, Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis, Circ Cardiovasc Imaging, 2, 191, 10.1161/CIRCIMAGING.108.819938 · DOI
  64. Voelkel, 2003, Pulmonary vascular involvement in chronic obstructive pulmonary disease, Eur Respir J Suppl, 46, 28s, 10.1183/09031936.03.00000503 · DOI
  65. Sinden, 2010, Systemic inflammation and comorbidity in COPD: a result of “overspill” of inflammatory mediators from the lungs? Review of the evidence, Thorax, 65, 930, 10.1136/thx.2009.130260 · DOI
  66. Liebow, 1959, Pulmonary emphysema with special reference to vascular changes, Am Rev Respir Dis, 80, 67
  67. Alford, 2010, Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers, Proc Natl Acad Sci U S A, 107, 7485, 10.1073/pnas.0913880107 · DOI
  68. Tjeerdsma, 2001, Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade, Eur J Heart Fail, 3, 33, 10.1016/S1388-9842(00)00119-7 · DOI
  69. Haider, 2009, Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease, J Hypertens, 27, 1648, 10.1097/HJH.0b013e32832c0018 · DOI
  70. Guder, 2012, GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study, Respir Res, 13, 13, 10.1186/1465-9921-13-13 · DOI
  71. Orozco-Levi, 2012, Injury of peripheral muscles in smokers with chronic obstructive pulmonary disease, Ultrastruct Pathol, 36, 228, 10.3109/01913123.2012.668611 · DOI
  72. van den Borst, 2013, Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD, J Appl Physiol, 114, 1319, 10.1152/japplphysiol.00508.2012 · DOI
  73. Diaz, 2013, CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD, Respir Med, 107, 570, 10.1016/j.rmed.2012.12.011 · DOI
  74. Van Remoortel, 2013, Daily physical activity in subjects with newly diagnosed COPD, Thorax, 68, 962, 10.1136/thoraxjnl-2013-203534 · DOI
  75. Vogiatzis, 2013, The physiological basis of rehabilitation in chronic heart and lung disease, J Appl Physiol, 115, 16, 10.1152/japplphysiol.00195.2013 · DOI
  76. Fletcher, 1977, The natural history of chronic airflow obstruction, Br Med J, 1, 1645, 10.1136/bmj.1.6077.1645 · DOI
  77. Celli, 2008, Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study, Am J Respir Crit Care Med, 178, 332, 10.1164/rccm.200712-1869OC · DOI
  78. Tashkin, 2008, A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, 359, 1543, 10.1056/NEJMoa0805800 · DOI · Paper page
  79. O'Donnell, 2011, Effects of BMI on static lung volumes in patients with airway obstruction, Chest, 140, 461, 10.1378/chest.10-2582 · DOI · Paper page
  80. Parker, 2005, Physiological changes during symptom recovery from moderate exacerbations of COPD, Eur Respir J, 26, 420, 10.1183/09031936.05.00136304 · DOI · Paper page
  81. Pitta, 2006, Physical activity and hospitalization for exacerbation of COPD, Chest, 129, 536, 10.1378/chest.129.3.536 · DOI
  82. Barnes, 2009, Systemic manifestations and comorbidities of COPD, Eur Respir J, 33, 1165, 10.1183/09031936.00128008 · DOI
  83. Burrows, 1964, Clinical types of chronic obstructive lung disease in London and in Chicago. A study of one hundred patients, Am Rev Respir Dis, 90, 14
  84. Tantucci, 2008, Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease, Respir Med, 102, 613, 10.1016/j.rmed.2007.11.004 · DOI · Paper page
  85. Zaman, 2010, Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation, Am J Med Sci, 339, 411, 10.1097/MAJ.0b013e3181d6578c · DOI
  86. Albuquerque, 2006, Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III, Eur Respir J, 28, 939, 10.1183/09031936.06.00040506 · DOI · Paper page
  87. Celli, 2003, Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes, Chest, 124, 1743, 10.1378/chest.124.5.1743 · DOI
  88. Guenette, 2011, Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD, Respir Med, 105, 1836, 10.1016/j.rmed.2011.08.021 · DOI
  89. O'Donnell, 2004, Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD, Eur Respir J, 23, 832, 10.1183/09031936.04.00116004 · DOI · Paper page
  90. O'Donnell, 2001, Evaluation of bronchodilator responses in patients with “irreversible” emphysema, Eur Respir J, 18, 914, 10.1183/09031936.01.00216501 · DOI
  91. O'Donnell, 2006, Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD, J Appl Physiol, 101, 1025, 10.1152/japplphysiol.01470.2005 · DOI · Paper page
  92. Laghi, 2003, Disorders of the respiratory muscles, Am J Respir Crit Care Med, 168, 10, 10.1164/rccm.2206020 · DOI
  93. Levine, 1997, Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease, N Engl J Med, 337, 1799, 10.1056/NEJM199712183372503 · DOI · Paper page
  94. Mercadier, 1998, Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation, Am J Physiol, 274, L527
  95. Orozco-Levi, 1999, Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease, Eur Respir J, 13, 371, 10.1183/09031936.99.13237199 · DOI · Paper page
  96. O'Donnell, 1997, Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms, Am J Respir Crit Care Med, 155, 109, 10.1164/ajrccm.155.1.9001298 · DOI
  97. Mead, 1973, Respiration: pulmonary mechanics, Annu Rev Physiol, 35, 169, 10.1146/annurev.ph.35.030173.001125 · DOI · Paper page
  98. Roussos, 1982, The respiratory muscles, N Engl J Med, 307, 786, 10.1056/NEJM198209233071304 · DOI · Paper page
  99. Smith, 1988, Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction, J Appl Physiol, 65, 1488, 10.1152/jappl.1988.65.4.1488 · DOI
  100. O'Donnell, 2012, Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise, Chest, 141, 753, 10.1378/chest.11-0787 · DOI · Paper page
  101. Laveneziana, 2011, Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints, Am J Respir Crit Care Med, 184, 1367, 10.1164/rccm.201106-1128OC · DOI
  102. O'Donnell, 2006, COPD exacerbations. 3: Pathophysiology, Thorax, 61, 354, 10.1136/thx.2005.041830 · DOI · Paper page
  103. Stevenson, 2005, Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, 1510, 10.1164/rccm.200504-595OC · DOI
  104. O'Donnell, 2002, Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation, Am J Respir Crit Care Med, 166, 663, 10.1164/rccm.2201003 · DOI · Paper page
  105. Marin, 2001, Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 163, 1395, 10.1164/ajrccm.163.6.2003172 · DOI
  106. Puente-Maestu, 2005, Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD, Chest, 128, 651, 10.1378/chest.128.2.651 · DOI
  107. Laveneziana, 2008, Exercise limitation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 4, 258
  108. Gagnon, 2012, Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 186, 606, 10.1164/rccm.201203-0404OC · DOI
  109. Guenette, 2012, Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?, Eur Respir J, 40, 322, 10.1183/09031936.00157711 · DOI · Paper page
  110. O'Donnell, 2012, Physiological effects of roflumilast at rest and during exercise in COPD, Eur Respir J, 39, 1104, 10.1183/09031936.00096511 · DOI
  111. O'Donnell, 2011, Effect of indacaterol on exercise endurance and lung hyperinflation in COPD, Respir Med, 105, 1030, 10.1016/j.rmed.2011.03.014 · DOI · Paper page
  112. O'Donnell, 2009, Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD, Eur Respir J, 34, 866, 10.1183/09031936.00168708 · DOI · Paper page
  113. Paoletti, 2011, Cardiopulmonary exercise testing (CPET) in pulmonary emphysema, Respir Physiol Neurobiol, 179, 167, 10.1016/j.resp.2011.07.013 · DOI
  114. Bye, 1985, Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation, Am Rev Respir Dis, 132, 236
  115. Mador, 2000, Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 161, 118, 10.1164/ajrccm.161.1.9903010 · DOI · Paper page
  116. Laveneziana, 2011, Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD, Eur J Appl Physiol, 111, 225, 10.1007/s00421-010-1643-z · DOI
  117. Travers, 2007, Effect of tiotropium bromide on the cardiovascular response to exercise in COPD, Respir Med, 101, 2017, 10.1016/j.rmed.2007.03.008 · DOI
  118. Chiappa, 2008, Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics, J Appl Physiol, 104, 1341, 10.1152/japplphysiol.01364.2007 · DOI · Paper page
  119. Montes de Oca, 1996, Respiratory muscle and cardiopulmonary function during exercise in very severe COPD, Am J Respir Crit Care Med, 154, 1284, 10.1164/ajrccm.154.5.8912737 · DOI · Paper page
  120. Saito, 1999, Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD, Chest, 115, 376, 10.1378/chest.115.2.376 · DOI
  121. Vassaux, 2008, Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD, Eur Respir J, 32, 1275, 10.1183/09031936.00151707 · DOI · Paper page
  122. Boerrigter, 2012, Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients, PloS One, 7, e30208, 10.1371/journal.pone.0030208 · DOI
  123. Boerrigter, 2012, Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension, Chest, 142, 1166, 10.1378/chest.11-2798 · DOI
  124. Ranieri, 1996, Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure, Eur Respir J, 9, 1283, 10.1183/09031936.96.09061283 · DOI · Paper page
  125. Tyberg, 2000, Effects of positive intrathoracic pressure on pulmonary and systemic hemodynamics, Respir Physiol, 119, 171, 10.1016/S0034-5687(99)00112-7 · DOI
  126. Hilde, 2013, Haemodynamic responses to exercise in patients with COPD, Eur Respir J, 41, 1031, 10.1183/09031936.00085612 · DOI · Paper page
  127. Jorgensen, 2007, Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study, Chest, 131, 1050, 10.1378/chest.06-2245 · DOI · Paper page
  128. Watz, 2010, Emphysema, airflow obstruction, and left ventricular filling, N Engl J Med, 362, 1638, 10.1056/NEJMc1002018 · DOI
  129. Watz, 2010, Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation, Chest, 138, 32, 10.1378/chest.09-2810 · DOI · Paper page
  130. Orr, 2012, Pulmonary hypertension in advanced chronic obstructive pulmonary disease, Curr Opin Pulm Med, 18, 138, 10.1097/MCP.0b013e32834f2093 · DOI
  131. Funk, 2008, Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure, Chest, 133, 1354, 10.1378/chest.07-2685 · DOI
  132. Criner, 2007, Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema, Am J Respir Crit Care Med, 176, 253, 10.1164/rccm.200608-1114OC · DOI · Paper page
  133. Criner, 2011, The National Emphysema Treatment Trial (NETT). Part II: lessons learned about lung volume reduction surgery, Am J Respir Crit Care Med, 184, 881, 10.1164/rccm.201103-0455CI · DOI
  134. Jorgensen, 2003, Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema, Chest, 124, 1863, 10.1378/chest.124.5.1863 · DOI
  135. Jorgensen, 2007, Left ventricular performance and dimensions in patients with severe emphysema, Anesth Analg, 104, 887, 10.1213/01.ane.0000258020.27849.6b · DOI
  136. Vonk Noordegraaf, 1997, The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema, Chest, 112, 640, 10.1378/chest.112.3.640 · DOI
  137. Mitchell, 2005, RV filling modulates LV function by direct ventricular interaction during mechanical ventilation, Am J Physiol Heart Circ Physiol, 289, H549, 10.1152/ajpheart.01180.2004 · DOI
  138. Larsen, 2008, Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A, Cardiovasc Res, 80, 47, 10.1093/cvr/cvn180 · DOI
  139. Lammi, 2012, Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation, Eur Respir J, 40, 837, 10.1183/09031936.00169311 · DOI
  140. Carrascossa, 2010, Haemodynamic effects of proportional assist ventilation during high-intensity exercise in patients with chronic obstructive pulmonary disease, Respirology, 15, 1185, 10.1111/j.1440-1843.2010.01846.x · DOI
  141. Oliveira, 2010, Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD, Eur J Appl Physiol, 109, 681, 10.1007/s00421-010-1408-8 · DOI
  142. Vogiatzis, 2011, Effect of helium breathing on intercostal and quadriceps muscle blood flow during exercise in COPD patients, Am J Physiol Regul Integr Comp Physiol, 300, R1549, 10.1152/ajpregu.00671.2010 · DOI
  143. Queiroga, 2013, Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD, Eur Respir J, 42, 362, 10.1183/09031936.00087812 · DOI · Paper page
  144. Berton, 2010, Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD, Thorax, 65, 588, 10.1136/thx.2009.120857 · DOI · Paper page
  145. Le Jemtel, 2007, Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure, J Am Coll Cardiol, 49, 171, 10.1016/j.jacc.2006.08.046 · DOI
  146. Laveneziana, 2012, Physical activity, nutritional status and systemic inflammation in COPD, Eur Respir J, 40, 522, 10.1183/09031936.00041212 · DOI
  147. Donaldson, 2012, Muscle function in COPD: a complex interplay, Int J Chron Obstruct Pulmon Dis, 7, 523
  148. Levine, 2013, COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans, J Appl Physiol, 114, 1235, 10.1152/japplphysiol.01121.2012 · DOI
  149. Meyer, 2013, Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target, Exp Physiol, 98, 1063, 10.1113/expphysiol.2012.069468 · DOI · Paper page
  150. Debigare, 2008, The major limitation to exercise performance in COPD is lower limb muscle dysfunction, J Appl Physiol, 105, 751, 10.1152/japplphysiol.90336.2008a · DOI
  151. Burtin, 2012, Effectiveness of exercise training in patients with COPD: the role of muscle fatigue, Eur Respir J, 40, 338, 10.1183/09031936.00111811 · DOI
  152. O'Donnell, 2007, Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable, Proc Am Thorac Soc, 4, 145, 10.1513/pats.200611-159CC · DOI
  153. O'Donnell, 2006, The clinical importance of dynamic lung hyperinflation in COPD, COPD, 3, 219, 10.1080/15412550600977478 · DOI · Paper page
  154. O'Donnell, 2009, Mechanisms of activity-related dyspnea in pulmonary diseases, Respir Physiol Neurobiol, 167, 116, 10.1016/j.resp.2009.01.010 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
O’Donnell, D. E., Laveneziana, P., Webb, K., & Neder, J. A.
Venue
Clinics in Chest Medicine
Publisher
Elsevier BV
Published
2014-03
Volume
35
Issue
1
Pages
51-69
ISSN
0272-5231
DOI
10.1016/j.ccm.2013.09.008
Cited by
121
References
17
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.